SenzaGen AB (STO:SENZA)
Sweden · Delayed Price · Currency is SEK 5.34
-0.06 (-1.11%)
May 29, 2026, 4:39 PM CET
SenzaGen AB Market Cap
SenzaGen AB has a market cap or net worth of 173.59 million as of May 29, 2026. Its market cap has increased by 1.44% in one year.
Market Cap
173.59M
Enterprise Value
153.32M
Revenue
59.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.34
Market Cap Chart
Since September 21, 2017, SenzaGen AB's market cap has decreased from 669.46M to 173.59M, a decrease of -74.07%. That is a compound annual growth rate of -14.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 173.59M | -3.23% |
| Dec 30, 2025 | 179.38M | -11.88% |
| Dec 30, 2024 | 203.58M | 15.61% |
| Dec 29, 2023 | 176.09M | -39.28% |
| Dec 30, 2022 | 289.98M | 22.62% |
| Dec 30, 2021 | 236.48M | -15.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 151.34B |
| Sectra AB | 52.21B |
| Getinge AB | 51.34B |
| Medicover AB | 31.25B |
| Klaria Pharma Holding AB (publ.) | 194.32M |
| Scandinavian Real Heart AB (Publ) | 177.60M |
| Active Biotech AB | 173.98M |
| Diamyd Medical AB | 168.93M |